Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / EFTR - eFFECTOR: Developing New Class Of Cancer Therapies

EFTR - eFFECTOR: Developing New Class Of Cancer Therapies

eFFECTOR Therapeutics Inc.
  • eFFECTOR Therapeutics is pioneering the development of a new class of oncology drugs known as STRIs.
  • The STRI therapy is also being evaluated for COVID-19 at UCSF under a DARPA grant.
  • The company’s stock commenced trading on Nasdaq on 8/26/2021 after merger with SPAC Locust Walk Acquisition Corp. (LWAC).

For further details see:

eFFECTOR: Developing New Class Of Cancer Therapies
Stock Information
Company Name: eFFECTOR Therapeutics Inc.
Stock Symbol: EFTR
Market: OTC
Website: effector.com
Menu
EFTR EFTR Quote EFTR Short EFTR News EFTR Articles EFTR Message Board
Get EFTR Alerts

News, Short Squeeze, Breakout and More Instantly...